...
首页> 外文期刊>Calcified tissue international. >Regulated expression of G protein-coupled receptor kinases (GRK's) and beta-arrestins in osteoblasts.
【24h】

Regulated expression of G protein-coupled receptor kinases (GRK's) and beta-arrestins in osteoblasts.

机译:G蛋白偶联受体激酶(GRK's)和β-arrestin在成骨细胞中的表达调控。

获取原文
获取原文并翻译 | 示例

摘要

Desensitization of G-protein coupled receptors (GPCR's) is largely mediated by a family of enzymes and protein co-factors termed GRKs and arrestins, respectively. In the present studies, we investigated expression of GRKs and arrestins in osteoblastic cell lines concentrating on the enzymes (GRK2 and GRK3) and protein co-factors (beta-arrestint 1 and beta-arrestin 2) that play dominant roles in regulating GPCR responsiveness in most tissues and cell types. We found that osteoblastic cells express similar amounts of GRK2 with either undetectable or lesser amounts of GRK3. In contrast, expression of beta-arrestin 1 and beta-arrestin 2 by osteoblastic cells varied between cell lines. To determine if GRK2 or beta-arrestin expression is modulated during osteoblast development, we assessed expression of GRK2 and beta-arrestin proteins during differentiation of the mouse osteoblastic cell line MC3T3-E1 cells over a 21-day period. We found that expression of GRK2 and beta-arrestin 2 increased to maximal levelsby day 7 and then decreased 4-fold by day 21. In contrast, expression of beta-arrestin 1 increased to maximal levels by day 14 and then decreased 2-fold by day 21. Over this same time period (days 7-21), PTH/PTHrP receptor number decreased to a greater extent than the decrease in PTH(1-34)-induced cAMP generation, suggesting that responsiveness of individual PTH/PTHrP receptors was enhanced in differentiated cells. We conclude that (1) osteoblastic cell lines differentially express the enzymes and protein co-factors that modulate GPCR responsiveness and (2) expression of both GRK2 and beta-arrestins is temporally regulated during osteoblast development. These data are consistent with the notion that GPCR responsiveness may be differentially regulated in osteoblastic cell lines and during osteoblast development.
机译:G蛋白偶联受体(GPCR's)的脱敏主要由分别称为GRKs和抑制蛋白的一族酶和蛋白辅因子介导。在本研究中,我们研究了成骨细胞系中GRKs和抑制蛋白的表达,这些酶集中于在调节GPCR反应性中起主要作用的酶(GRK2和GRK3)和蛋白质辅因子(β-arrestint1和β-arrestin2)。大多数组织和细胞类型。我们发现,成骨细胞表达相似量的GRK2或检测不到或较少量的GRK3。相反,成骨细胞对β-arrestin1和β-arrestin2的表达在细胞系之间有所不同。为了确定成骨细胞发育过程中是否调节了GRK2或β-arrestin的表达,我们评估了21天的小鼠成骨细胞系MC3T3-E1细胞分化过程中GRK2和β-arrestin蛋白的表达。我们发现,GRK2和β-arrestin2的表达在第7天增加到最大水平,然后在第21天下降4倍。相反,β-arrestin1的表达在第14天增加到最大水平,然后在第22天下降2倍。第21天。在同一时间段(第7-21天),PTH / PTHrP受体数量的下降幅度大于PTH(1-34)诱导的cAMP生成的下降幅度,这表明单个PTH / PTHrP受体的响应能力是在分化细胞中增强。我们得出结论,(1)成骨细胞系差异表达调节GPCR反应性的酶和蛋白质辅因子,(2)GRK2和β-arrestins的表达在成骨细胞发育过程中受到时间调节。这些数据与在成骨细胞系和成骨细胞发育过程中GPCR反应性可能受到不同调节的观点相一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号